Akebia Therapeutics, Inc. (AKBA)
NASDAQ: AKBA · Real-Time Price · USD
1.310
-0.010 (-0.76%)
At close: Feb 27, 2026, 4:00 PM EST
1.310
0.00 (-0.01%)
After-hours: Feb 27, 2026, 7:52 PM EST

Akebia Therapeutics Cash Flow Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
FY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Net Income
-5.35-69.41-51.93-94.23-282.02
Depreciation & Amortization
1.2737.537.6337.737.97
Loss (Gain) From Sale of Assets
-0.17----
Asset Writedown & Restructuring Costs
--0.788.77-
Loss (Gain) From Sale of Investments
-----0.02
Stock-Based Compensation
11.287.789.3217.8522.74
Provision & Write-off of Bad Debts
1.480.88---
Other Operating Activities
43.0122.271.54-41.873.98
Change in Accounts Receivable
-14.144.050.9911.3-24.03
Change in Inventory
-23.13-28.4-2.5419.09-24.95
Change in Accounts Payable
3.08-1.36-5.241.5-11.74
Change in Unearned Revenue
2.68--3.744.651.82
Change in Other Net Operating Assets
47.98-13.96-10.2-37.98-46.72
Operating Cash Flow
67.99-40.66-23.38-73.15-252.97
Capital Expenditures
-0.29-0.03--0.11-0.06
Sale of Property, Plant & Equipment
0.17----
Sale (Purchase) of Intangibles
-7.81----
Investment in Securities
----40
Investing Cash Flow
-7.93-0.03--0.1139.94
Long-Term Debt Issued
1045---
Long-Term Debt Repaid
-4.23-37.1-32-33-
Net Debt Issued (Repaid)
5.777.9-32-33-
Issuance of Common Stock
68.3643.036.797.688.95
Other Financing Activities
-1.21-1.27-4044.78
Financing Cash Flow
72.9349.66-25.2114.6133.73
Net Cash Flow
132.998.97-48.59-58.67-79.29
Free Cash Flow
67.7-40.69-23.38-73.27-253.02
Free Cash Flow Margin
28.66%-25.40%-12.02%-25.05%-119.55%
Free Cash Flow Per Share
0.26-0.19-0.13-0.40-1.52
Cash Interest Paid
6.085.046.066.769.63
Levered Free Cash Flow
68.6113.6317.9-15.3-136.04
Unlevered Free Cash Flow
83.732521.67-5.5-123.53
Change in Working Capital
16.47-39.68-20.73-1.44-105.61
Updated Feb 26, 2026. Source: S&P Global Market Intelligence. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q